Forum Discussion
Giovanna_BCNA
8 years agoMember
CDK Inhibitors approved by PBAC 20 April 2018
CDK Inhibitors approved by the Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue.
See the link below for further informationhttps://www.bcna.org.au/news/2018/04/cdk-inhibitors-approved-by-pbac-but-costs-still-an-issue/
19 Replies
- wendy55MemberSO very pleased to hear and read the news, will be a game changer for those women who will soon be able to afford this drug ,just a bit sad that it looks like it will only be for those as a first line of treatment, and that I will not be able to access them, I will discuss with my oncologist when I see him next month, perhaps by then we will have a clearer picture of who can and who cannot have them.
wendy55 - mum2jjMemberGood news, that will hopefully become great news with cost being factored in for all to have access who need it.
- SoldierCrabMemberAwesome news
- MoiraCMemberGreat news -now we need a reasonable price and soon. Thanks to BCNA and lots of others for advocacy on this.
- KattykitMemberThat is great news
- KatyJoyMemberAlmost there! Well done everyone,
- jennyssMemberGreat news @Giovanna_BCNA
- iserbrownMemberWoo hoo! another step closer!
- brightspaceMemberMany thanks for heads up on progress but we still have a long way to go as has been said in discussion.
Good luck to the newly diagonised metters who will hopefuly benefit
Bright in hope